Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.

Source:http://linkedlifedata.com/resource/pubmed/id/19448533

Download in:

View as

General Info

PMID
19448533